Precigen
PGEN
#4603
Rank
S$3.17 B
Marketcap
S$8.86
Share price
-3.34%
Change (1 day)
51.69%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): -S$0.27 Billion

According to Precigen's latest financial reports the company's current earnings are S$31.59 Million. In 2025 the company made an earning of -S$0.32 Billion a decrease over its 2024 earnings that were of -S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.27 Billion-17.66%
2025 -S$0.32 Billion95.77%
2024 -S$0.17 Billion32.86%
2023 -S$0.13 Billion20.5%
2022 -S$0.11 Billion-23.33%
2021 -S$0.14 Billion60.11%
2020 -S$83.03 Million-65.1%
2019 -S$0.24 Billion-65.19%
2018 -S$0.69 Billion313.44%
2017 -S$0.17 Billion-33.2%
2016 -S$0.25 Billion123.22%
2015 -S$0.12 Billion1.47%
2014 -S$0.11 Billion109.54%
2013 -S$52.14 Million-50.04%
2012 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-S$3.17 Million-98.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-S$93.12 Million-64.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-S$82.16 Million-68.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-S$0.19 Billion-27.22% Jersey